{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:30Z","timestamp":1747181190394,"version":"3.40.5"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,2]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Turner syndrome is characterized by complete or partial loss of the second sex chromosome. In patients with Turner syndrome, hypertension is well described. However, the literature regarding malignant hypertension is scarce. Therefore, an accurate and timely diagnosis and treatment are important.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 13-year-old female with Turner syndrome presented to the emergency department with malignant hypertension, headache, spraying vomiting, convulsion, and loss of consciousness. Considering her medical history, symptoms, and auxiliary examination, secondary hypertension (primary reninism) was suspected, but without any occupying or hyperplasia in renal and adrenal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>A type of secondary hypertension, primary reninism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was immediately transferred to the pediatric intensive care unit. Subsequently, she was given nifedipine 0.35\u2009mg\/kg and captopril 0.35mg\/kg to reduce blood pressure (BP), mannitol and furosemide to reduce cranial pressure, and phenobarbital and midazolam to terminate restlessness successively. Three hours later, the BP was consistently higher than 170\/120\u2009mm Hg, sodium nitroprusside was pumped intravenously, then, giving oral drug transition. Finally, she was given Valsartan-Amlodipine Tablets (I) (80\u2009mg valsartan and 5\u2009mg amlodipine per day) and bisoprolol (2.5\u2009mg per day).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>For 2.5 years of follow-up, the BP reduced to 110\u2013130\/60\u201385\u2009mm Hg, heart rate ranged between 65 and 80 bpm, and she could go to school without any headache, convulsion, and syncope.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The clinical phenotype of Turner syndrome is complex and varied, affecting multiple systems and organs. Turner syndrome with malignant hypertension is rare, so we should systematically evaluate secondary hypertension, target-organ damage, and accompanied by standard management when Turner syndrome presents with hypertension.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000039128","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T17:36:32Z","timestamp":1722620192000},"page":"e39128","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Malignant hypertension in a patient with Turner syndrome: A case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0087-2648","authenticated-orcid":false,"given":"Ying","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, China"},{"name":"Department of Cardiology, Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China"},{"name":"Department of Cardiology, Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Department of Cardiology, Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, China"},{"name":"Department of Cardiology, Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China"},{"name":"Department of Cardiology, Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Department of Cardiology, Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, China"},{"name":"Department of Cardiology, Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China"},{"name":"Department of Cardiology, Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Department of Cardiology, Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, China"},{"name":"Department of Cardiology, Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China"},{"name":"Department of Cardiology, Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Department of Cardiology, Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Department of Central Laboratory, Central Laboratory, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyang","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, China"},{"name":"Department of Cardiology, Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China"},{"name":"Department of Cardiology, Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Department of Cardiology, Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, China"},{"name":"Department of Cardiology, Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China"},{"name":"Department of Cardiology, Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Department of Cardiology, Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Department of Pediatrics, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People\u2019s Hospital, Yichang, China"},{"name":"Department of Cardiology, Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China"},{"name":"Department of Cardiology, Hubei Key Laboratory of Ischemic Cardiovascular Disease, Yichang, China"},{"name":"Department of Cardiology, Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease, Yichang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0430","article-title":"Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting.","volume":"177","author":"Gravholt","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/HJH.0000000000003321","article-title":"Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions.","volume":"41","author":"Jones","year":"2023","journal-title":"J Hypertens"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2265.2000.00960.x","article-title":"Blood pressure and Turner syndrome.","volume":"52","author":"Nathwani","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1161\/HYP.0000000000000228","article-title":"Pediatric primary hypertension: an underrecognized condition: a scientific statement from the American Heart Association.","volume":"80","author":"Falkner","year":"2023","journal-title":"Hypertension"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"680803","DOI":"10.3389\/fped.2021.680803","article-title":"Hypertension in children and adolescents: a position statement from a panel of multidisciplinary experts coordinated by the French Society of Hypertension.","volume":"9","author":"Bouhanick","year":"2021","journal-title":"Front Pediatr"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1093\/eurheartj\/ehac328","article-title":"Hypertension in children and adolescents.","volume":"43","author":"de Simone","year":"2022","journal-title":"Eur Heart J"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamapediatrics.2019.3310","article-title":"Global prevalence of hypertension in children: a systematic review and meta-analysis.","volume":"173","author":"Song","year":"2019","journal-title":"JAMA Pediatr"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2265.2006.02483.x","article-title":"Physiological and catecholamine response to sympathetic stimulation in Turner syndrome.","volume":"64","author":"Zuckerman-Levin","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.hjh.0000200509.17947.0f","article-title":"Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome.","volume":"24","author":"Gravholt","year":"2006","journal-title":"J Hypertens"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"bcr2014208777","DOI":"10.1136\/bcr-2014-208777","article-title":"Renal denervation for severe hypertension in a small child with Turner syndrome: miniaturisation of the procedure and results.","volume":"2015","author":"Bonanni","year":"2015","journal-title":"BMJ Case Rep"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3390\/cells12101365","article-title":"Organ abnormalities caused by Turner syndrome.","volume":"12","author":"Yoon","year":"2023","journal-title":"Cells"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s41440-024-01606-w","article-title":"Clinical features, laboratory findings and treatment of juxtaglomerular cell tumors: a systemic review.","volume":"47","author":"Dong","year":"2024","journal-title":"Hypertens Res"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"31","DOI":"10.17925\/EE.2023.19.2.11","article-title":"Endocrine hypertension: the urgent need for greater global awareness.","volume":"19","author":"Fernandez","year":"2023","journal-title":"touchREV Endocrinol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:12:35Z","timestamp":1746317555000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":13,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039128","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}